Inmecin 50mg Capsule contains Indomethacin, a nonsteroidal anti-inflammatory drug (NSAID) indicated for the management of moderate to severe pain, inflammation, and stiffness associated with conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute gouty arthritis. Indomethacin exerts its therapeutic effects primarily through the inhibition of cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins, which are mediators of inflammation and pain. This capsule formulation delivers a 50mg dose, suitable for adult patients requiring potent anti-inflammatory and analgesic therapy. Inmecin should be administered with caution in patients with a history of gastrointestinal disorders, cardiovascular disease, renal or hepatic impairment, and should be avoided in those with known hypersensitivity to NSAIDs. Common adverse effects include gastrointestinal discomfort, nausea, dyspepsia, and dizziness, with serious risks such as gastrointestinal bleeding, ulceration, and renal toxicity necessitating careful monitoring during prolonged use. It is recommended to use the lowest effective dose for the shortest duration consistent with treatment goals. Concomitant use with other NSAIDs, anticoagulants, or corticosteroids should be approached cautiously to minimize adverse effects. Inmecin 50mg Capsule is a valuable therapeutic option for inflammatory conditions when used under appropriate medical supervision.